Brief: Allena Pharmaceuticals Reports Q1 Loss Per Share Of $0.31
May 13 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS REPORTS FIRST QUARTER 2020
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q1 LOSS PER SHARE $0.31
* Q1 EARNINGS PER SHARE ESTIMATE $-0.45 -- REFINITIV IBES
DATA
* AS OF MARCH 31, 2020, CASH AND CASH EQUIVALENTS WERE $20.5
MILLION, AS COMPARED TO $30.0 MILLION AS OF DECEMBER 31, 2019
Source text for Eikon: ID:nGNXbByKTL
Further company coverage: ALNA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allena Pharmaceuticals
See all newsBrief: Allena Pharmaceuticals Inc - On September 6, Received Notice From Nasdaq That Its Shares Will Be Suspended At Open Of Business On September 8, 2022
U.S. STOCKS ON THE MOVE-Relmada, Entera Bio, Eli Lilly
U.S. STOCKS ON THE MOVE-ChannelAdvisor, HyreCar, ADT, miners
U.S. STOCKS ON THE MOVE-Timken, Bed Bath & Beyond, HyreCar, chip stocks
Allena down on bankruptcy filing